• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Poland·Healthcare·ENE.WA
Share

Centrum Medyczne ENEL-MED S.A. Stocks

PLN 19.2Last Updated 25.06.2026

Issuer Rating

3/7
Performance

Modest

Risk

Considerable

Recommendation

Sell

Market Cap

PLN 143.88M

PLN 19.2
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Centrum Medyczne ENEL-MED S.A., a prominent healthcare provider established in 1993, operates from its Warsaw, Poland base, offering an extensive array of medical services nationwide. These provisions encompass specialized consultations, dentistry, orthopedics, infertility treatments, physical rehabilitation, psychological support, and comprehensive diagnostic capabilities. Additionally, they provide vaccinations, emergency care, and surgical interventions to their patients.

Company Valuation

Slightly overvalued
3/7

From both historical and forecast perspectives, the stock is slightly overpriced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, neutral on EV/

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

27.06.2026 09:42

SpaceX will be added to the Nasdaq 100 index as early as July. What does this mean for investors?

27.06.2026 03:48

OpenAI restricted access to the new version of ChatGPT at the request of the Trump administration

27.06.2026 03:12

Moderna shares hit a two-year high after a 13% surge. It's all about a new treatment

27.06.2026 01:53

The U.S. launched strikes against Iran in response to an attack on a commercial vessel in the Strait of Hormuz

27.06.2026 01:07

The Nasdaq fell 4% following the worst week of the year for semiconductor stocks

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026